| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1115417B1 Use of daptomycin |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | EP1051162B1 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate |
| 04/05/2006 | EP1041976B1 Polyamide oligomers |
| 04/05/2006 | EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 04/05/2006 | EP1017840B1 NOVEL $i(SERRATIA MARCESCENS) STRAIN, PRODIGIOSIN AND THE USE OF THE SAME AS AN IMMUNOSUPPRESSIVE |
| 04/05/2006 | EP0981514B1 3-epi vitamin d2 compounds and uses thereof |
| 04/05/2006 | EP0965339B1 Tabletted nateglinide preparation |
| 04/05/2006 | EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 04/05/2006 | EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 04/05/2006 | EP0862453B1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 04/05/2006 | EP0800397B1 Bone mass anabolic composition comprising olpadronate |
| 04/05/2006 | EP0710288B1 Adenoviral vectors for treatment of hemophilia |
| 04/05/2006 | CN1756850A Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 04/05/2006 | CN1756845A Adenoviral vector vaccine |
| 04/05/2006 | CN1756758A Novel cantharidimide and norcantharidimide derivant and its application in medicine |
| 04/05/2006 | CN1756757A Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents |
| 04/05/2006 | CN1756756A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756755A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756754A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 04/05/2006 | CN1756753A Benzofuran derivative |
| 04/05/2006 | CN1756752A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756751A Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 04/05/2006 | CN1756750A Adiponectin expression promoter |
| 04/05/2006 | CN1756748A 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1756744A Pyridinium salts, compounds and methods of use |
| 04/05/2006 | CN1756741A Lipid metabolism improving agent |
| 04/05/2006 | CN1756737A Process for preparing 2-cyano-3-hydroxy-n-(phenyl)but-2-enamides |
| 04/05/2006 | CN1756728A 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it |
| 04/05/2006 | CN1756567A Body weight gain inhibitor |
| 04/05/2006 | CN1756566A Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 04/05/2006 | CN1756554A Novel chemical entities and methods for their use in treatment of metabolic disorders |
| 04/05/2006 | CN1756553A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 04/05/2006 | CN1756552A Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 04/05/2006 | CN1756551A New arylpiperazinyl compounds |
| 04/05/2006 | CN1756550A 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-HT6 modulators |
| 04/05/2006 | CN1756549A Antineoplastic combinations comprising a rapamycin dderiovative and an aromatse inhibitor |
| 04/05/2006 | CN1756548A Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases |
| 04/05/2006 | CN1756547A 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1756545A Use of omega-3-fatty acids in the treatment of diabetic patients |
| 04/05/2006 | CN1756544A Use of arachidonic acid for normalization of infradian rhythm |
| 04/05/2006 | CN1756543A Inhibitor for liver cancer onset and progress |
| 04/05/2006 | CN1756542A Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases |
| 04/05/2006 | CN1756541A Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid |
| 04/05/2006 | CN1756540A Use of non-immunosuppressant 2-nipecoti acid derivative in inducing chondrosis and differentiation |
| 04/05/2006 | CN1756538A Stable oral benzimidazole compositions and processes for their preparation |
| 04/05/2006 | CN1756537A Sustained release system and method for ocular delivery of carbonic anhydrase inhibitors |
| 04/05/2006 | CN1756536A Composition and method for treating age-related disorders |
| 04/05/2006 | CN1756533A Non-pegylated long-circulating liposomes |
| 04/05/2006 | CN1756532A Topical stabilized prostaglandin E compound dosage forms |
| 04/05/2006 | CN1756527A Regulation of mammalian hair growth |
| 04/05/2006 | CN1756484A Microbicidal compositions including an ionene polymer and 2,4,4acoe-trichloro-2acoe-hydroxydiphenyl ether, and methods of using the same |
| 04/05/2006 | CN1754892A Preparation method and application of Asiatic polysaccharide |
| 04/05/2006 | CN1754884A Crystal form ii of clarithromycin |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754879A Imidazole derivative compound, its salts and use thereof |
| 04/05/2006 | CN1754878A Strontium ranelate alpha crystalline form, method for the preparation thereof and pharmaceutical compositions containing said agent |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1754871A Preparation method and use of alpine yarrow herb ketoacid |
| 04/05/2006 | CN1754556A Compound kudzu root and glibenclamide pharmaceutical composition and its preparation method |
| 04/05/2006 | CN1754554A Traditional Chinese medicine compositions |
| 04/05/2006 | CN1754552A Use of alpine yarrow herb effective parts in preparing medicine for respiratory tract virus |
| 04/05/2006 | CN1754541A Steroid saponin pharmaceutical composition and its preparation method and uses |
| 04/05/2006 | CN1754540A Medicine containing general pasqueflower saponin composition and its preparation method and uses |
| 04/05/2006 | CN1754539A Tetrodotoxin oil phase formulation preparation method |
| 04/05/2006 | CN1754538A Methotrexate oral disintegrating tablet and its preparation method |
| 04/05/2006 | CN1754537A Pharmaceutical composition containing zaleplon and its preparation method |
| 04/05/2006 | CN1754536A Solution formulations of sirolimus and its analogs for cad treatment |
| 04/05/2006 | CN1754535A Paclitaxel analog microsphere for topical injection, its preparation method and uses |
| 04/05/2006 | CN1754534A Lysine hydrochlorate for injection and its preparation method |
| 04/05/2006 | CN1754533A Tamoxifen citrate oral disintegrating tablet and its preparation method |
| 04/05/2006 | CN1249233C Surface proteins of chlamydia pneumoniae |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249091C Fibre containing composition for enteral nutrition |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249076C Anti-tumour ginseng saponin aglycone derivatives |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249072C Preparation method of golden peach glycoside and its new use in medicine |
| 04/05/2006 | CN1249067C Extracting process for bilobalide A, B, C and its preparation |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249064C Tosylate and benzene sulfonate of pyrazolopy ridone compound |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/05/2006 | CN1249061C Sulfonamide and sulfamide substituted imidazoquinolines and its pharmaceutical composition and uses |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/05/2006 | CN1249057C Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 04/05/2006 | CN1249053C Nitrate salt of anti-ulcer medicine |
| 04/05/2006 | CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |